North America

Thu
14
Feb

Use of cannabis becomes more prevalent in cancer treatment

In the past few decades, medical institutions had begun to use cannabis a form of treatment, as a result of its multifarious therapeutic effects. Researchers have conducted years of studies in order to understand the plant and its effects further. Positive results have thus allowed the integration of cannabis into medical facilities, but it also helped propel the global legalization efforts. The active components in cannabis, THC and CBD, are linked to possessing beneficial effects on the body, which make them popular options for treatment. Currently, cannabis is predominately being used to treat mild to severe medical conditions such as chronic pain, cancer, epilepsy, and seizures.

Thu
14
Feb

Cannabis stocks climb ahead of congressional hearing on bank access

Cannabis shares were higher Wednesday ahead of a congressional hearing on the obstacles facing cannabis companies when it comes to opening and maintaining bank accounts.

A subcommittee of the Democratic-controlled House Financial Services Committee will meet to hear testimony on the topic at 2 p.m. Eastern time. For now, cannabis companies are unable to hold accounts at federally backed banks, because weed is still subject to a federal ban, another issue that is hampering the development of the sector in those states that have legalized cannabis for medical or recreational use.

Thu
14
Feb

What the heck is nebulizing? And is it the next big thing for consuming cannabis?

Anyone who knows someone with severe asthma might recognize a nebulizing machine. If not, the device is likely a complete mystery.

Thu
14
Feb

Parkinson’s Foundation will gather experts to study cannabis as disease therapy

These days, people with Parkinson’s disease tend to ask their doctors more questions about cannabis than any other subject; yet, few physicians have adequate answers for them.

So says a new survey announced by the Parkinson’s Foundation, which plans a conference on that subject next month in Denver.

The March 6-7 meeting will bring together about 40 top scientists, clinicians, physicians and marijuana industry executives, said James Beck, MD, the foundation’s chief scientific officer.

Thu
14
Feb

A cannabis-friendly veterinarian shares his tips for giving CBD to pets

When pets get ill or experience anxiety, most owners would do just about anything to fix the situation, so it's not surprising that many pet owners have tried giving medical marijuana to their furry friends, writes Sara Ritchie. Now veterinarians are starting to follow suit. As more and more research has come out in support of using medical marijuana for pets, veterinarians like Dr. Robert Klostermann have begun giving the cannabis compound cannabidiol (CBD) to their four-legged companions.

Thu
14
Feb

Should you buy, sell, or hold these 7 medical cannabis stocks?

Cannabis stocks are having a blistering start to 2019. The sector appeared to have peaked in the fall of 2018. As many had warned, marijuana stocks turned sharply lower following Canada’s legalization going into effect in a classic “sell the news” event. However, since then, the tide has turned. This year, pot stocks are back with the sector ETF posting a 50% move off the lows.

Not surprisingly, this enthusiasm has carried both recreational and medicinal cannabis stocks higher. For today, let’s focus on the medicinal space. The recreational plays have been getting more attention lately with all the blockbuster partnerships. However, there are some interesting business stories developing in the medical cannabis stock space as well.

Thu
14
Feb

The last fairly valued marijuana stock?

The Horizons Medical Marijuana Life Sciences exchange-traded fund (ETF) holds a basket of more than four-dozen marijuana stocks and has climbed by more than 50% year to date. This is after the most stellar year for pot stocks on record.

In anticipation of the October 17th legalization of recreational marijuana sales across Canada, pot stocks shot up to historic highs. Canopy , the clear leader in this space , is up 100% over the same period and is now valued at a forward price-to-sales ratio of 62.5, assuming quarterly revenues cross $60 million after legalization.

Wed
13
Feb

Kurvana capitalizes on vape pen trends

The vape pen category has shown enormous growth in the cannabis industry, but not all vapes are created equal. Consumers are also beginning to show a preference in their purchasing habits when it comes to vapes as well. Kurvana has kept an eye on these trends and has managed to make a product to satisfy multiple consumers.

Wed
13
Feb

3 most important takeaways from aurora cannabis' quarterly results

Aurora Cannabis' (NYSE:ACB) is targeting 570,000 kilograms of cannabis production someday, and that goal has it neck-and-neck with Canopy Growth (NYSE:CGC) in the race to be the world's top pot stock. The company's fiscal second-quarter results, which were unveiled Monday night, provide important insight into Canada's fledgling recreational marijuana market.

Wed
13
Feb

Opinion: Aurora Cannabis is a prime example of why marijuana investors should focus on money flows

Late last month, optimism was building among average investors about Aurora Cannabis’ earnings.

Even though they continued to buy Aurora Cannabis ACB, -0.14%  stock in the days leading up to the company’s earnings report after the stock market closed Monday, many were surprised to see the stock fall. Bulls were expecting the stock to hit $10. But Aurora Cannabis peaked Feb. 4 at a little over $8.ACB, -0.14%

Many investors are still oblivious of the froth in marijuana stocks. They continue to believe that all they have to do is buy a few stocks like Aurora Cannabis and they will become rich.

Pages

Subscribe to RSS - North America